Stockreport

NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF Strengthens Global IP Portfolio for PrimeC Through 2042CAMBRIDGE, Mass., Feb. 9, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late- [Read more]